This page includes the latest FDA filings for Atricure Inc 7555 Innovation Waymason Oh 45040 Pma Numberp100046 Supplement Numbers013 Date Received03 01 2022 Decision Date11 15 2022 Product Code Ocm Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
ATRICURE INC.7555 Innovation Waymason, OH 45040 PMA NumberP100046 Supplement NumberS013 Date Received03/01/2022 Decision Date11/15/2022 Product Code OCM Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No | AtriCure Synergy Ablation System | 2022-11-15 |